154454 - Know your injectables: Helping GPs advance patients with T2D from oral to injectable therapy
1. Pre-disposing activity: case study-based reflective activity to be completed prior to the meeting.
2. Face-to-Face: attendance at an interactive half-day meeting
3. Reinforcing activity: case study-based reflective activity to be completed after the meeting
Nearly half of Australians with diabetes are not at HbA1c target. Patients with type 2 diabetes often experience prolonged periods of suboptimal glycaemic control before initiation of injectable therapy. Timely transition from oral to injectable therapies represents an important strategy in increasing the number of patients at HbA1c target. This may require challenging current barriers in both clinicians and patients that lead to delays, e.g. clinical inertia and fear of needles.
GPs, in collaboration with a multidisciplinary team, play a key role in helping patients successfully transition to injectable therapies. This case-based meeting aims to provide GPs with practical information that will assist them in advancing patients with type 2 diabetes from oral to injectable therapies, with the ultimate goal of improving the health outcomes of Australians